A reversible early oxidized redox state that precedes macromolecular ROS damage in aging nontransgenic and 3xTg-AD mouse neurons

Journal of Neuroscience

Volumn 32, Issue 17, 2012, Pages 5821-5832

  Ghosh, Debolina ^a   LeVault, Kelsey R ^a   Barnett, Aaron J ^a   Brewer, Gregory J ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CALCIUM ION; CYTOCHROME C; FLAVINE ADENINE NUCLEOTIDE; GLUTATHIONE; NICOTINAMIDE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

AGE; ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CELL SURVIVAL; COGNITIVE DEFECT; CONTROLLED STUDY; EXCITOTOXICITY; GENOTYPE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NERVE CELL LESION; NERVE FIBER REGENERATION; NONHUMAN; OXIDATION REDUCTION POTENTIAL; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ADENINE NUCLEOTIDES; AGING; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CALCIUM; CELLS, CULTURED; CEREBRAL CORTEX; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOCHROMES C; DISEASE MODELS, ANIMAL; GLUTATHIONE; HIPPOCAMPUS; HUMANS; HYDROGEN PEROXIDE; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUTATION; NAD; NEURONS; NIACINAMIDE; OXIDANTS; OXIDATION-REDUCTION; PRESENILIN-1; REACTIVE OXYGEN SPECIES; TAU PROTEINS; VITAMIN B COMPLEX;

EID: 84860170321     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.6192-11.2012     Document Type: Article

References (52)

1. 2+ dysregulation and neuronal death through activation of ionotropic glutamate receptors. Cell Calcium 47:264-272.
2. Anderson RM, Weindruch R (2010) Metabolic reprogramming, caloric restriction and aging. Trends Endocrinol Metab 21:134-141.
3. Brewer GJ (1997) Isolation and culture of adult rat hippocampal neurons. J Neurosci Methods 71:143-155.
4. Brewer GJ (2010) Epigenetic oxidative redox shift (EORS) theory of aging unifies the free radical and insulin signaling theories. Exp Gerontol 45:173-179.
5. Brewer GJ, Torricelli JR (2007) Isolation and culture of adult neurons and neurospheres. Nat Protoc 2:1490-1498.
6. Brewer GJ, Torricelli JR, Evege EK, Price PJ (1993) Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serumfree medium combination. J Neurosci Res 35:567-576.
7. Brewer GJ, Reichensperger JD, Brinton RD (2006) Prevention of age-related dysregulation of calcium dynamics by estrogen in neurons. Neurobiol Aging 27:306-317.
8. Brewer GJ, Torricelli JR, Lindsey AL, Kunz EZ, Neuman A, Fisher DR, Joseph JA (2010) Age-related toxicity of amyloid-beta associated with increased pERK and pCREB in primary hippocampal neurons: reversal by blueberry extract. J Nutr Biochem 21:991-998.
9. Bubber P, Haroutunian V, Fisch G, Blass JP, Gibson GE (2005) Mitochondrial abnormalities in Alzheimer brain: mechanistic implications. Ann Neurol 57:695-703.
10. Butterfield DA, Koppal T, Howard B, Subramaniam R, Hall N, Hensley K, Yatin S, Allen K, Aksenov M, Aksenova M, Carney J (1998) Structural and functional changes in proteins induced by free radicalmediated oxidative stress and protective action of the antioxidants N-tert-butyl-alpha-phenylnitrone and vitamin E. Ann N Y Acad Sci 854:448-462.
11. Carney JM, Smith CD, Carney AM, Butterfield DA (1994) Aging-and oxygen-induced modifications in brain biochemistry and behavior. Ann N Y Acad Sci 738:44-53.
12. Chance B, Williams GR (1956) Respiratory enzymes in oxidative phosphorylation, VI: the effects of adenosine diphosphate on azide-treated mitochondria. J Biol Chem 221:477-489.
13. Chance B, Schoener B, Oshino R, Itshak F, Nakase Y (1979) Oxidationreduction ratio studies of mitochondria in freeze-trapped samples. NADH and flavoprotein fluorescence signals. J Biol Chem 254:4764-4771.
14. Das KC, White CW (2002) Redox systems of the cell: possible links and implications. Proc Natl Acad Sci U S A 99:9617-9618.
15. Emerit J, Edeas M, Bricaire F (2004) Neurodegenerative diseases and oxidative stress. Biomed Pharmacother 58:39-46.
16. Eng J, Lynch RM, Balaban RS (1989) Nicotinamide adenine dinucleotide fluorescence spectroscopy and imaging of isolated cardiac myocytes. Biophys J 55:621-630.
17. Green KN, Steffan JS, Martinez-Coria H, Sun X, Schreiber SS, Thompson LM, LaFerla FM (2008) Nicotinamide restores cognition in Alzheimer's disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau. J Neurosci 28:11500-11510.
18. Gupte SA, Kaminski PM, Floyd B, Agarwal R, Ali N, Ahmad M, Edwards J, Wolin MS (2005) Cytosolic NADPH may regulate differences in basal Nox oxidase-derived superoxide generation in bovine coronary and pulmonary arteries. Am J Physiol Heart Circ Physiol 288:H13-H21.
19. Hensley K, Maidt ML, Yu Z, Sang H, Markesbery WR, Floyd RA (1998) Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation. J Neurosci 18:8126-8132.
20. Hoyer A, Bardenheuer HJ, Martin E, Plaschke K (2005) Amyloid precursor protein (APP) and its derivatives change after cellular energy depletion: an in vitro-study. J Neural Transm 112:239-253.
21. Hoyer S, Oesterreich K, Wagner O (1988) Glucose metabolism as the site of the primary abnormality in early-onset dementia of Alzheimer type? J Neurol 235:143-148.
22. Hulbert PB, Yakubu SI (1983) Monobromobimane: a substrate for the fluorometric assay of glutathione transferase. J Pharm Pharmacol 35: 384-386.
23. Jones DP (2006) Redefining oxidative stress. Antioxid Redox Signal 8:1865-1879.
24. Jones TT, Brewer GJ (2010) Age-related deficiencies in complex I endogenous substrate availability and reserve capacity of complex IV in cortical neuron electron transport. Biochim Biophys Acta 1797: 167-176.
25. Kalyanaraman B, Darley-Usmar V, Davies KJ, Dennery PA, Forman HJ, Grisham MB, Mann GE, Moore K, Roberts LJ 2nd, Ischiropoulos H (2012) Measuring reactive oxygen and nitrogen species with fluorescent probes: challenges and limitations. Free Radic Biol Med 52:1-6.
26. Khachaturian ZS (1994) Calcium hypothesis of Alzheimer's disease and brain aging. Ann N Y Acad Sci 747:1-11.
27. Klaidman LK, Leung AC, Adams JD Jr (1995) High-performance liquid chromatography analysis of oxidized and reduced pyridine dinucleotides in specific brain regions. Anal Biochem 228:312-317.
28. Klaidman LK, Mukherjee SK, Adams JD Jr (2001) Oxidative changes in brain pyridine nucleotides and neuroprotection using nicotinamide. Biochim Biophys Acta 1525:136-148.
29. Kudo H, Kokunai T, Kondoh T, Tamaki N, Matsumoto S (1990) Quantitative analysis of glutathione in rat central nervous system: comparison of GSH in infant brain with that in adult brain. Brain Res 511:326-328.
30. Lai JC, Cooper AJ (1986) Brain alpha-ketoglutarate dehydrogenase complex: kinetic properties, regional distribution, and effects of inhibitors. J Neurochem 47:1376-1386.
31. Lee WH, Kumar A, Rani A, Herrera J, Xu J, Someya S, Foster TC (2012) Influence of viral vector-mediated delivery of superoxide dismutase and catalase to the hippocampus on spatial learning and memory during aging. Antioxid Redox Signal 16:339-350.
32. 2+] in adult Alzheimer's disease mice. J Neurochem 105:262-271.
33. Martin B, Ji S, Maudsley S, Mattson MP (2010) "Control" laboratory rodents are metabolically morbid: why it matters. Proc Natl Acad Sci U S A 107:6127-6133.
34. Mattson MP, LaFerla FM, Chan SL, Leissring MA, Shepel PN, Geiger JD (2000) Calcium signaling in the ER: its role in neuronal plasticity and neurodegenerative disorders. Trends Neurosci 23:222-229.
35. Montine KS, Reich E, Neely MD, Sidell KR, Olson SJ, Markesbery WR, Montine TJ (1998) Distribution of reducible 4-hydroxynonenal adduct immunoreactivity in Alzheimer disease is associated with APOE genotype. J Neuropathol Exp Neurol 57:415-425.
36. Nicholls DG (2009) Mitochondrial calcium function and dysfunction in the central nervous system. Biochim Biophys Acta 1787:1416-1424.
37. Nunomura A, Perry G, Pappolla MA, Wade R, Hirai K, Chiba S, Smith MA (1999) RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease. J Neurosci 19:1959-1964.
38. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM (2003a) Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular A+ and synaptic dysfunction. Neuron 39:409-421.
39. Oddo S, Caccamo A, Kitazawa M, Tseng BP, LaFerla FM (2003b) Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease. Neurobiol Aging 24:1063-1070.
40. Parihar MS, Brewer GJ (2007) Simultaneous age-related depolarization of mitochondrial membrane potential and increased mitochondrial reactive oxygen species production correlate with age-related glutamate excitotoxicity in rat hippocampal neurons. J Neurosci Res 85:1018-1032.
41. Parihar MS, Kunz EA, Brewer GJ (2008) Age-related decreases in NAD(P)H and glutathione cause redox declines before ATP loss during glutamate treatment of hippocampal neurons. J Neurosci Res 86:2339-2352.
42. Patel JR, Brewer GJ (2003) Age-related changes in neuronal glucose uptake in response to glutamate and beta-amyloid. J Neurosci Res 72:527-536.
43. Reed TT, Pierce WM, Markesbery WR, Butterfield DA (2009) Proteomic identification of HNE-bound proteins in early Alzheimer disease: insights into the role of lipid peroxidation in the progression of AD. Brain Res 1274:66-76.
44. Resende R, Moreira PI, Proenca T, Deshpande A, Busciglio J, Pereira C, Oliveira CR (2008) Brain oxidative stress in a triple-transgenic mouse model of Alzheimer disease. Free Radic Biol Med 44:2051-2057.
45. Safdar A, Hamadeh MJ, Kaczor JJ, Raha S, Debeer J, Tarnopolsky MA (2010) Aberrant mitochondrial homeostasis in the skeletal muscle of sedentary older adults. PLoS One 5:e10778.
46. Schulz JB, Lindenau J, Seyfried J, Dichgans J (2000) Glutathione, oxidative stress and neurodegeneration. Eur J Biochem 267:4904-4911.
47. Smith IF, Green KN, LaFerla FM (2005a) Calcium dysregulation in Alzheimer's disease: recent advances gained from genetically modified animals. Cell Calcium 38:427-437.
48. Smith IF, Hitt B, Green KN, Oddo S, LaFerla FM (2005b) Enhanced caffeine-induced Ca2_ release in the 3xTg-AD mouse model of Alzheimer's disease. J Neurochem 94:1711-1718.
49. Smith MA, Sayre LM, Anderson VE, Harris PL, Beal MF, Kowall N, Perry G (1998) Cytochemical demonstration of oxidative damage in Alzheimer disease by immunochemical enhancement of the carbonyl reaction with 2,4-dinitrophenylhydrazine. J Histochem Cytochem 46:731-735.
50. Stutzmann GE, Smith I, Caccamo A, Oddo S, Laferla FM, Parker I (2006) Enhanced ryanodine receptor recruitment contributes to Ca2_ disruptions in young, adult, and aged Alzheimer's disease mice. J Neurosci 26:5180-5189.
51. Yao J, Irwin RW, Zhao L, Nilsen J, Hamilton RT, Brinton RD (2009) Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A 106:14670-14675.
52. Ying W (2008) NAD+/NADH and NADP+/NADPH in cellular functions and cell death: regulation and biological consequences. Antioxid Redox Signal 10:179-206.